PharmAbs is a KU Leuven innovation, valorisation and incubation platform for the development of antibody-based therapeutics and diagnostics. PharmAbs’ expertise and technologies are used to translate basic scientific innovations emerging at universities into diagnostic/therapeutic solutions for personalized medicine that can be implemented in the clinic and/or commercialized by third parties.
PharmAbs offers antibody solutions to academic groups and companies.
Technology offers and licensing opportunities.
PharmAbs established a structural collaboration with KU Leuven MeBios to develop integrated diagnostics and life science research tools
Company Details
- Employees
- 6
- Founded
- -
- Address
- Herestraat 49, Leuven,vlaanderen 3000,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pharmabs.org
- Keywords
- Stellaris Therapeutics.
- HQ
- Leuven, Vlaanderen
Pharmabs Questions
Pharmabs's website is pharmabs.org
Pharmabs's LinkedIn profile is https://be.linkedin.com/company/pharmabs
Pharmabs has
6 employees.
View email and phone details for 6
employees at Pharmabs.
Pharmabs's industry is
Biotechnology Research
Pharmabs's top competitors are
Hemastatx,
Stellaris Therapeutics,
Ucb,
272bio Limited,
Senap Symposium,
Techbiot Edf Project,
Maedia Consulting,
Integrated Dna Technologies,
Montis Biosciences,
Icometrix.
Pharmabs's categories are Biotechnology Research
Pharmabs's founding year is 2008
